Desq Long
Sign in

Company

Attovia Therapeutics, Inc.

ATTO · CIK 0002058707

SEC FORM 4
$0.00

Attovia Therapeutics, Inc. (ATTO)

Acquisition (code C) of 1,957,134 shares at $0 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code C

Traded Aug 6, 2026 · Disclosed Aug 28, 2026FILED +22 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$0.00

Attovia Therapeutics, Inc. (ATTO)

Acquisition (code C) of 478,498 shares at $0 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code C

Traded Aug 6, 2026 · Disclosed Aug 28, 2026FILED +22 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$0.00

Attovia Therapeutics, Inc. (ATTO)

Acquisition (code C) of 1,957,134 shares at $0 per share.

Reporting Person WALSH COLIN · Transaction Code C

Traded Aug 6, 2026 · Disclosed Aug 28, 2026FILED +22 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$0.00

Attovia Therapeutics, Inc. (ATTO)

Acquisition (code C) of 478,498 shares at $0 per share.

Reporting Person WALSH COLIN · Transaction Code C

Traded Aug 6, 2026 · Disclosed Aug 28, 2026FILED +22 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$2,211.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 100 shares at $22.11 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$16,543.41

Attovia Therapeutics, Inc. (ATTO)

Sale of 753 shares at $21.97 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$14,797.44

Attovia Therapeutics, Inc. (ATTO)

Sale of 672 shares at $22.02 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$153,549.10

Attovia Therapeutics, Inc. (ATTO)

Sale of 6,970 shares at $22.03 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$8,808.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 400 shares at $22.02 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$25,771.20

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,180 shares at $21.84 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$22,932.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,040 shares at $22.05 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$6,252.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 300 shares at $20.84 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$9,648.54

Attovia Therapeutics, Inc. (ATTO)

Sale of 443 shares at $21.78 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$4,410.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 200 shares at $22.05 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$21,765.64

Attovia Therapeutics, Inc. (ATTO)

Sale of 988 shares at $22.03 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$15,449.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 700 shares at $22.07 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$25,806.97

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,163 shares at $22.19 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$2,199.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 100 shares at $21.99 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$146,148.43

Attovia Therapeutics, Inc. (ATTO)

Sale of 6,763 shares at $21.61 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$1,607,834.72

Attovia Therapeutics, Inc. (ATTO)

Sale of 76,418 shares at $21.04 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$9,775.89

Attovia Therapeutics, Inc. (ATTO)

Sale of 447 shares at $21.87 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$29,343.96

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,332 shares at $22.03 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$4,410.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 200 shares at $22.05 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$34,325.36

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,556 shares at $22.06 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$74,912.04

Attovia Therapeutics, Inc. (ATTO)

Sale of 3,402 shares at $22.02 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$4,420.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 200 shares at $22.10 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$10,344.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 480 shares at $21.55 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

SEC FORM 4
$2,211.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 100 shares at $22.11 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$16,543.41

Attovia Therapeutics, Inc. (ATTO)

Sale of 753 shares at $21.97 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$14,797.44

Attovia Therapeutics, Inc. (ATTO)

Sale of 672 shares at $22.02 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$153,549.10

Attovia Therapeutics, Inc. (ATTO)

Sale of 6,970 shares at $22.03 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$8,808.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 400 shares at $22.02 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$25,771.20

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,180 shares at $21.84 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$22,932.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,040 shares at $22.05 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$6,252.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 300 shares at $20.84 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$9,648.54

Attovia Therapeutics, Inc. (ATTO)

Sale of 443 shares at $21.78 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$4,410.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 200 shares at $22.05 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$21,765.64

Attovia Therapeutics, Inc. (ATTO)

Sale of 988 shares at $22.03 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$15,449.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 700 shares at $22.07 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$25,806.97

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,163 shares at $22.19 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$2,199.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 100 shares at $21.99 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$146,148.43

Attovia Therapeutics, Inc. (ATTO)

Sale of 6,763 shares at $21.61 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$1,607,834.72

Attovia Therapeutics, Inc. (ATTO)

Sale of 76,418 shares at $21.04 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$9,775.89

Attovia Therapeutics, Inc. (ATTO)

Sale of 447 shares at $21.87 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$29,343.96

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,332 shares at $22.03 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$4,410.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 200 shares at $22.05 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$34,325.36

Attovia Therapeutics, Inc. (ATTO)

Sale of 1,556 shares at $22.06 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$74,912.04

Attovia Therapeutics, Inc. (ATTO)

Sale of 3,402 shares at $22.02 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$4,420.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 200 shares at $22.10 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4
$10,344.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 480 shares at $21.55 per share.

Reporting Person WALSH COLIN · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →

SEC FORM 4CLUSTER · 2 INSIDERS
$20,570,000.00

Attovia Therapeutics, Inc. (ATTO)

Purchase of 1,170,000 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • GOLDMAN SACHS GROUP INCPurchase of 85,000 shares at $21 per share.$1,785,000.00
  • WALSH COLINPurchase of 85,000 shares at $21 per share.$1,785,000.00
  • GOLDMAN SACHS GROUP INCPurchase of 500,000 shares at $17 per share.$8,500,000.00
  • WALSH COLINPurchase of 500,000 shares at $17 per share.$8,500,000.00

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

Source: SEC Form 4 · 0001866174-26-000011 · filed 2026-08-28 · View filing →